dual agonist glp 1 Efficacy of glucagon-like peptide-1 and estrogen in pancreatic islets protection and pre-clinical models of insulin-deficient diabetes Engineering a potent and long-acting

This is the unlikely journey from desert predator to medical marvel.

Injection-site reactions and worsening of pre-existing diabetic retinopathy are also relevant clinical concerns

Tirzepatide), metabolic outcomes, and next-gen weight loss benefits

A new case report highlights the potential risk of "anhedonia" from high doses of tirzepatide, though it can be treated effectively.

GLP-1RAs reduce events linked to atherogenic cardiovascular disease (especially ischemic stroke) and also renal outcomes (FLOW trial with semaglutide), with a limited effect on heart failure

New content online: The role of GLP1 receptor agonists in adult-onset type 1 diabetes mellitus